Bersanlimab
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54) . Bersanlimab has anticancer effects[1].
Product Specifications
CAS Number
1987854-08-9
Product Name Alternative
BI-505
UNSPSC
12352203
Target
Integrin
Type
Inhibitory Antibodies
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bersanlimab.html
Purity
99.85
Solubility
10 mM in DMSO
Smiles
[Bersanlimab]
Molecular Weight
(144.22 kDa)
References & Citations
[1]Niina Veitonmäki, et al. A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo. Cancer Cell. 2013 Apr 15;23 (4) :502-15.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033707-01 10 µg
Recombinant Human Langerin/CD207 Protein (His Tag)
Sign In for Pricing
View Details PKSH033707-02 50 µg
Recombinant Human Langerin/CD207 Protein (His Tag)
Sign In for Pricing
View Details 
BNC882290-500 1x 500 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/2290R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details